MTOR Suppresses Cigarette Smoke-Induced Airway Inflammation and MMP12 Expression in Macrophage in Chronic Obstructive Pulmonary Disease

Lingling Dong,Yong Wang,Haipin Chen,Zhouyang Li,Xuchen Xu,Jiesen Zhou,Huahao Shen,Zhihua Chen

DOI: https://doi.org/10.2147/copd.s426333

2024-01-24

International Journal of COPD

Abstract:Lingling Dong, 1, &ast Yong Wang, 1, &ast Haipin Chen, 1 Zhouyang Li, 1 Xuchen Xu, 1 Jiesen Zhou, 1 Huahao Shen, 1, 2 Zhihua Chen 1 1 Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhihua Chen, Department of Respiratory and Critical Care Medicine, Key Laboratory of Respiratory Disease of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, People's Republic of China, Tel +86-571-8898-1913, Fax +86-571-8778-3729, Email Background: Macrophage-derived matrix metalloproteinase 12 (MMP12) can cause destruction of lung tissue structure and plays a significant role in the development and progression of chronic obstructive pulmonary disease (COPD). MTOR is a serine/threonine kinase that plays a crucial role in cell growth and metabolism. The activity of MTOR in the lung tissues of COPD patients also shows significant changes. However, it is unclear whether MTOR can regulate the development and progression of COPD by controlling MMP12. This study primarily investigates whether MTOR in macrophages can affect the expression of MMP12 and participate in the progression of COPD. Methods: We tested the changes in MTOR activity in macrophages exposed to cigarette smoke (CS) both in vivo and in vitro. Additionally, we observed the effect of MTOR on the expression of MMP12 in macrophages and on lung tissue inflammation and structural damage in mice, both in vivo and in vitro, using MTOR inhibitors or gene knockout mice. Finally, we combined inhibitor treatment with gene knockout to demonstrate that MTOR primarily mediates the expression of MMP12 through the NF-κB signaling pathway. Results: Exposure to CS can enhance MTOR activity in mouse alveolar macrophages. Inhibiting the activity of MTOR or suppressing its expression leads to increased expression of MMP12. Myeloid-specific knockout of MTOR expression can promote the occurrence of CS-induced pulmonary inflammation and emphysema in mice. Inhibiting the activity of NF-κB can eliminate the effect of MTOR on MMP12. Conclusion: Macrophage MTOR can reduce the expression of MMP12 by inhibiting NF-κB, thereby inhibiting the occurrence of COPD inflammation and destruction of lung tissue structure. Activating the activity of macrophage MTOR may be beneficial for the treatment of COPD. Keywords: matrix metalloproteinase 12, MMP12, pulmonary emphysema, cigarette smoke, CS, mechanistic target of rapamycin, MTOR Chronic obstructive pulmonary disease (COPD) is associated with an inflammatory response to inhaled toxins, especially cigarette smoke (CS), and is a leading cause of mortality in the world. 1,2 However, the underlying mechanisms of COPD pathogenesis are still unclear. Mechanistic target of rapamycin (MTOR), a serine/threonine kinase, plays a central role in cellular growth and metabolism. 3,4 MTOR exists in two distinct multiprotein complexes, MTORC1 and MTORC2. 5 MTORC1 can activate multiple downstream molecules to regulate different cellular functions, including mRNA transcription, protein synthesis, lipid synthesis, nucleotide synthesis, and autophagy. 4 It has been shown that MTOR plays a crucial role in a variety of physiological and pathological processes, containing neurodegenerative diseases, aging, cancer, and obesity. 6–8 However, much remains to be explored about the in vivo function of MTOR in the pathogenesis of COPD. We have previously reported that reduced MTOR expression was observed in lung tissue of patients with COPD, and knockout of MTOR in bronchial epithelial or alveolar type 2 cells contributed to the formation of emphysema. 9 In contrast, increased MTOR activity was found in peripheral blood monocytes from COPD patients. 10 Besides, inhibition of MTOR activity can ameliorate corticosteroid resistance in COPD. 10 These results suggest that MTOR may play different roles in distinct cell types. Prior research has demonstrated that emphysema's pathogenesis involves crucial stages such as protease-antiprotease imbalance, oxidative stress, chronic lung inflammation, alveolar cell apoptosis, and autophagy. 11 Recently, alveolar macrophages have garnered increasing attention as significant end -Abstract Truncated-

respiratory system